Role of nitric oxide on the increased vascular permeability and neutrophil accumulation induced by staphylococcal enterotoxin B into the mouse paw

被引:19
作者
Franco-Penteado, CF [1 ]
Desouza, I [1 ]
Teixeira, SA [1 ]
Ribeiro-DaSilva, G [1 ]
De Nucci, G [1 ]
Antunes, E [1 ]
机构
[1] UNICAMP, Fac Med Sci, Dept Pharmacol, BR-13081970 Campinas, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
plasma exudation; paw oedema; neutrophils; enterotoxins; aminoguanidine;
D O I
10.1016/S0006-2952(01)00573-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The role of nitric oxide (NO) on the increase in vascular permeability and neutrophil migration induced by staphylococcal enterotoxin B (SEB: 25 mug/paw) in the mouse was investigated in this study. The NO synthase inhibitor N-omega-nitro-L-arginine methyl ester (L-NAME) [but not its inactive enantiomer N-omega-nitro-D-arginine methyl ester (D-NAME)I, given intravenously (25-100 mu moL/kg) or subplantarly (0.25-1.0 mu mol/paw). reduced SEE-induced paw oedema significantly. A similar response was observed with aminoguanidine, given either intravenously (200-600 mu mol/kg) or subplantarly (2 mu mol/paw). In contrast to paw oedema. the plasma exudation in response to SEE was not affected by the subplantar injection of L-NAME or aminoguanidine. The inhibition of oedema and plasma exudation by systemic treatment with L-NAME or aminoguanidine was reversed by co-injection of the vasodilator iloprost (0.3 nmol/paw). Subplantar injection of SEE (25 mug/paw) increased by 69% the myeloperoxidase (MPO) activity of SEE-treated paws, indicating the presence of neutrophils. Intravenous (12.5-50 mu mol/kg) or subplantar (0.125-0.5 mu mol/paw) administration of L-NAME (but not of its inactive enantiomer, D-NAME) largely reduced the MPO activity in SEE-treated paws. Similarly, intravenous (200-600 mu mol/kg) or subplantar (2 mu mol/paw) administration of aminoguanidine significantly reduced the MPO values of the SEE-injected paws. The vasodilator iloprost (0.3 nmol/paw) completely reversed the inhibition by L-NAME or aminoguanidine of the MPO activity in SEE-injected paws. Our results show that the increased vascular permeability and neutrophil accumulation in response to subplantar injection of SEE in the mouse are inhibited by L-NAME and aminoguanidine by mechanisms probably involving reduction of local microvascular blood Row. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1305 / 1311
页数:7
相关论文
共 44 条
  • [1] BELENKY SN, 1993, J LAB CLIN MED, V122, P388
  • [2] MEASUREMENT OF CUTANEOUS INFLAMMATION - ESTIMATION OF NEUTROPHIL CONTENT WITH AN ENZYME MARKER
    BRADLEY, PP
    PRIEBAT, DA
    CHRISTENSEN, RD
    ROTHSTEIN, G
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1982, 78 (03) : 206 - 209
  • [3] AMINOGUANIDINE, A NOVEL INHIBITOR OF NITRIC-OXIDE FORMATION, PREVENTS DIABETIC VASCULAR DYSFUNCTION
    CORBETT, JA
    TILTON, RG
    CHANG, K
    HASAN, KS
    IDO, Y
    WANG, JL
    SWEETLAND, MA
    LANCASTER, JR
    WILLIAMSON, JR
    MCDANIEL, ML
    [J]. DIABETES, 1992, 41 (04) : 552 - 556
  • [4] Desouza IA, 1996, J NAT TOXINS, V5, P341
  • [5] Desouza IA, 1996, J NAT TOXINS, V5, P61
  • [6] Inhibition of eosinophil chemotaxis by chronic blockade of nitric oxide biosynthesis
    Ferreira, HHA
    Medeiros, MV
    Lima, CSP
    Flores, CA
    Sannomiya, P
    Antunes, E
    DeNucci, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 310 (2-3) : 201 - 207
  • [7] THE PROTECTIVE ROLE OF ENDOGENOUSLY SYNTHESIZED NITRIC-OXIDE IN STAPHYLOCOCCAL-ENTEROTOXIN B-INDUCED SHOCK IN MICE
    FLORQUIN, S
    AMRAOUI, Z
    DUBOIS, C
    DECUYPER, J
    GOLDMAN, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) : 1153 - 1158
  • [8] REGIONAL DISTRIBUTION OF EDRF NO-SYNTHESIZING ENZYME(S) IN RAT-BRAIN
    FORSTERMANN, U
    GORSKY, LD
    POLLOCK, JS
    SCHMIDT, HHHW
    HELLER, M
    MURAD, F
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 168 (02) : 727 - 732
  • [9] GREGA GJ, 1988, MICROCIRC ENDOTH LYM, V4, P143
  • [10] AMINOGUANIDINE SELECTIVELY INHIBITS INDUCIBLE NITRIC-OXIDE SYNTHASE
    GRIFFITHS, MJD
    MESSENT, M
    MACALLISTER, RJ
    EVANS, TW
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (03) : 963 - 968